Film-forming composition

ES3084533T3Undetermined Publication Date: 2026-11-13URGO RECHERCHE INNOVATION & DÉVELOPPEMENT (100 00)
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
ES2016815887T
Authority / Receiving Office
ES · ES
Patent Type
Patents
Current Assignee / Owner
Filing Date
2016-11-25
Publication Date
2026-11-13
Estimated Expiration
2036-11-25

AI Technical Summary

Technical Problem

Current nail treatments for brittle and weakened nails often contain harsh ingredients like formaldehyde and require nail polish remover for removal, and they do not provide effective strengthening and smoothing benefits.

Method used

A film-forming composition comprising a keratin-derived polymer, moisturizing agent, and surfactant in a pharmaceutically acceptable medium, which forms a protective film on nails without formaldehyde, dries quickly, and is transparent and matte, applied to form a uniform film on weakened nails.

Benefits of technology

The composition significantly improves nail splitting, thinning, brittleness, and hardness after 14 and 28 days of use, with noticeable effects on nail color and smoothing, and does not require removal with nail polish remover.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to a liquid film-forming composition comprising at least one keratin-derived film-forming polymer, at least one moisturizing agent, and at least one surfactant in a pharmaceutically acceptable medium. The invention also relates to a method for obtaining a film from said liquid film-forming composition, as well as to the film obtainable by said method. The invention further relates to the therapeutic use of said liquid film-forming composition or said film for protecting the skin, mucous membranes, hair, and nails. The invention also relates to a cosmetic treatment method for weakened nails, as well as to the use of said liquid film-forming composition or said film for improving the appearance and / or strengthening weakened nails.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to a film-forming liquid composition comprising at least one keratin-derived film-forming polymer, at least one moisturizing agent, and at least one surfactant in a pharmaceutically acceptable medium. The invention also relates to a method for obtaining a film from said film-forming liquid composition, as well as the film obtainable by said method. The invention further relates to the therapeutic use of said film-forming liquid composition or said film for the protection of skin, mucous membranes, or hair and nails. The invention also relates to a method for the cosmetic treatment of brittle nails, as well as to the use of said film-forming liquid composition or said film to improve the appearance and / or strengthen brittle nails.

[0002] Film-forming compositions are designed to be applied, with or without an applicator, to tissues such as skin, hair and nails, and mucous membranes. They can also be used as liquid dressings, applied to wounds, lesions, scars, burns, and / or skin conditions. They are generally liquid upon application and typically contain a film-forming polymer dissolved in a volatile solvent, usually water or alcohol. Evaporation of the solvent then allows the formation of a protective solid film.

[0003] Documents EP 2 149 367 and WO 91 / 02538 A1 describe nail compositions. Document US 2015 / 030643 concerns amine silicone nanoemulsions that can be used to protect surfaces against soiling or wetting. Document WO 91 / 12793 describes mascaras. Document EP 2 583 663 describes a composition and its use on keratinous materials. Document US 2007 / 086966 describes an anti-aging cosmetic composition. Document WO 2009 / 035970 describes a composition for smoothing hair for at least 2-3 months.US document 2006 / 165635 describes cosmetic product formulations containing keratin and their use on keratinous materials. The invention thus relates, according to a first aspect, to a liquid film-forming composition comprising, in a pharmaceutically acceptable medium, at least one film-forming polymer derived from keratin present in the composition in a dry matter content ranging from 0.2% to 1% by weight, relative to the total weight of the composition; at least one moisturizing agent selected from the group consisting of glycerin in association with squalane, present in the composition in a dry matter content ranging from 1% to 10% by weight; and at least one surfactant selected from vegetable gums, polyacrylic acids, polyethylene glycol, polysorbates, and mixtures thereof, present in the composition in a dry matter content ranging from 1% to 10%; and the composition being characterized in that it contains neither formaldehyde nor parabens.

[0004] According to a second aspect, the invention also relates to a method for obtaining a film from the previously described liquid film-forming composition, comprising the following steps: i. The said composition is applied to the weakened nails in such a way as to form a uniform film, ii. It is left to dry for 1 to 5 minutes.

[0005] According to a third aspect, the invention also relates to the film that can be obtained by the process of the invention.

[0006] According to a fourth aspect, the invention relates to the therapeutic use of the liquid film-forming composition or the film according to the invention for the protection of the skin, hair and nails and mucous membranes.

[0007] According to a fifth aspect, the invention has as its object a method of cosmetic treatment of weakened nails comprising the application of the film-forming liquid composition according to the invention to the nails, preferably at least once a day, more preferably twice a day.

[0008] According to a final aspect, the invention also relates to the use of the liquid film-forming composition or the film according to the invention to improve the appearance and / or strengthen weakened nails.

[0009] In particular, the liquid film-forming composition according to the invention is physiologically acceptable, that is to say, it is non-toxic and can be applied to tissues such as skin, wounds, hair or mucous membranes of humans or animals and allows the formation of a biocompatible film.

[0010] For the purposes of this application, a liquid composition is defined as a composition that flows under its own weight.

[0011] Currently marketed nail treatments for brittle and weakened nails contain harsh ingredients, such as formaldehyde. Therefore, many require nail polish remover for removal.

[0012] The composition according to the present invention has the following advantages: It dries quickly (less than a minute); it does not require nail polish remover to be removed; it is transparent and matte; it contains no formaldehyde or parabens; it has a pleasant fragrance.

[0013] A clinical study on the composition according to the invention revealed: a significant beneficial effect on nail splitting after 14 and 28 days of use; a significant beneficial effect on nail thinning after 14 and 28 days of use; a significant beneficial effect on nail brittleness after 14 and 28 days of use; a significant beneficial hardening effect after 14 and 28 days of use; a beneficial effect on nail color after 14 and 28 days of use; a beneficial smoothing effect after 14 and 28 days of use. Film-forming polymer derived from keratin

[0014] The composition according to the invention comprises at least one film-forming polymer derived from keratin.

[0015] According to the present invention, "film-forming polymer" means a polymer capable of forming, either alone or in the presence of an auxiliary film-forming agent, a continuous and adherent film on a support, in particular on the skin or hair.

[0016] In the context of the present invention, the film-forming polymer is a keratin-derived polymer.

[0017] For the purposes of this invention, "keratin-derived polymer" means a polymer obtained by modifying keratin.

[0018] Keratin is an insoluble, helical-shaped fibrous protein found primarily in the hair, nails, and skin of humans and animals. The amino acids present in keratin vary depending on its source. Keratin can be extracted from animal sources, such as horns, hooves, wool, and feathers, as well as eggshell membranes.

[0019] According to a preferred embodiment, the keratin-derived polymer is hydrolyzed keratin.

[0020] Hydrolyzed keratin can be obtained, in particular, by chemical or enzymatic hydrolysis of keratin.

[0021] The keratin-derived polymer may also be a modified keratin, i.e., keratin or hydrolyzed keratin that has been modified by one or more chemical reactions such as, in particular, a succinylation, quaternization, esterification or amidation reaction with a fatty acid, sulfonylation or oxidation.

[0022] The keratin-derived polymer is present in the composition according to the invention in a dry matter content ranging from 0.2% to 1% by weight, relative to the total weight of the composition. Moisturizing agent

[0023] The composition according to the invention comprises at least one moisturizing agent selected from the group consisting of glycerin in association with squalane, present in the composition in a dry matter content ranging from 1% to 10% by weight.

[0024] For the purposes of this invention, "moisturizing agent" means an agent capable of increasing the water content of the skin or skin appendages.

[0025] Preferably, the moisturizing agent is present in the composition according to the invention in a dry matter content ranging from 2% to 7% by weight, relative to the total weight of the composition. Surfactant

[0026] The composition according to the invention comprises at least one surfactant.

[0027] A surfactant is a compound that modifies the surface tension between two surfaces.

[0028] The surfactant can be chosen from among vegetable gums, polyacrylic acids, polyethylene glycol, polysorbates, and mixtures thereof.

[0029] An example of a polyacrylic acid usable as a surfactant is a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid and the 2-hydroxyethyl ester of propenoic acid. The term "salt of 2-methyl-2-[(1-oxo-2-propenylamino]-1-propanesulfonic acid" refers to any type of salt known to those skilled in the art, such as sodium, potassium, or ammonium salts, preferably a sodium salt. Such a product is marketed, for example, by the company SEPPIC under the trade name SEPINOV EMT 10.

[0030] Preferably, the surfactant is a copolymer of a salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid and the 2-hydroxyethyl ester of propenoic acid used alone or in association with a polysorbate, preferably polysorbate 60.

[0031] The surfactant is present in a dry matter content ranging from 1 to 10%, preferably 2 to 6% by weight relative to the total weight of the composition. Pharmaceutically acceptable environment

[0032] The composition according to the invention comprises a pharmaceutically acceptable medium comprising at least one solvent.

[0033] For the purposes of this application, a pharmaceutically acceptable medium is defined as a medium that is compatible with the skin.

[0034] In particular, the pharmaceutically acceptable medium includes a solvent compatible with the keratin-derived film-forming polymer; preferably, a hydro-alcoholic solvent will be used.

[0035] The pharmaceutically acceptable medium may represent from 30 to 95% by weight, preferably from 60 to 90% by weight relative to the total weight of the composition. Secondary film-forming polymer

[0036] The composition according to the invention may include, in addition to the keratin-derived film-forming polymer, a secondary film-forming polymer.

[0037] Among the secondary film-forming polymers that can be used in the composition of the present invention, we can mention synthetic polymers, of radical type or of polycondensate type, polymers of natural origin, and their mixtures.

[0038] The secondary film-forming polymer can be chosen in particular from cellulosic polymers such as nitrocellulose, cellulose acetate, cellulose acetobutyrate, cellulose acetopropionate, ethyl cellulose, or even polyurethanes, acrylic polymers, vinyl polymers, polyvinyl butyrals, alkyd resins, resins derived from aldehyde condensation products such as arylsulfonamide formaldehyde resins like toluene sulfonamide formaldehyde resin, aryl-sulfonamide epoxy resins or even ethyl tosylamide resins, vinyl methyl ether and maleic anhydride copolymer (PVM / MA), and their mixtures.

[0039] As a secondary film-forming polymer, one can notably use nitrocellulose RS 1 / 8 sec; RS [1 / 4] sec.; [1 / 2] sec.; RS 5 sec.; RS 15 sec.; RS 35 sec.; RS 75 sec.; RS 150 sec; AS [1 / 4] sec.; AS [1 / 2] sec.; SS [1 / 4] sec.; SS [1 / 2] sec.; SS 5 sec., notably marketed by the company HERCULES, or nitrocellulose DHL 120 / 170 IPA marketed by the company NOBEL; toluene sulfonamide formaldehyde resins "Ketjentflex MS80" from AKZO or "Santolite MHP", "Santolite MS 80" from FACONNIER or "RESIMPOL 80" from PAN AMERICANA, alkyd resin "BECKOSOL ODE 230-70-E" from DAINIPPON, acrylic resin "ACRYLOID B66" from ROHM & HAAS, polyurethane resin "TRIXENE PR 4127" from BAXENDEN.

[0040] The secondary film-forming polymer may in particular be present in the composition according to the invention in a dry matter content ranging from 5 to 25% by weight, preferably ranging from 5 to 10% by weight, relative to the total weight of the composition. Auxiliary film coating agent

[0041] To improve the film-forming properties of the composition, an auxiliary film-forming agent can advantageously be added.

[0042] The auxiliary film-forming agent is, obviously, different from the solvent present in the pharmaceutically acceptable medium, from the keratin-derived film-forming polymer, and from the secondary film-forming polymer.

[0043] Such an auxiliary film-forming agent may be chosen from among all compounds known to a person skilled in the art, as being capable of fulfilling the desired function, and may in particular be chosen from among the plasticizing agents and the coalescing agents of the film-forming polymer(s).

[0044] Thus, the composition may also include at least one film-forming auxiliary selected from a plasticizer and / or a coalescing agent. In particular, common plasticizers and coalescing agents, used alone or in mixtures, include: fatty alcohols such as octyldodecanol, 2-butyloctanol, 2-hexyl decanol, 2-undecylpentadecanol, oleic alcohol; glycols and their derivatives, such as glycerin, diethylene glycol ethyl ether, diethylene glycol methyl ether, diethylene glycol butyl ether, diethylene glycol hexylether, ethylene glycol ethyl ether, ethylene glycol butyl ether, ethylene glycol hexylether; fatty acids such as oleic acid, linoleic acid, linolenic acid; glycol esters such as triacetin (or glyceryl triacetate); propylene glycol derivatives and in particular propylene glycol phenyl ether, propylene glycol diacetate, dipropylene glycol ethyl ether, tripropylene glycol methyl ether, propylene glycol butyl ether;acid esters, particularly carboxylic acids, such as citrates, phthalates, adipates, carbonates, tartrates, phosphates, sebacates and in particular monocarboxylic acid esters such as isononyl isononanoate, oleyl erucate or octyl-2-docecyl neopentanoate;oxyethylenated derivatives, such as oxyethylenated oils, including vegetable oils such as sesame oil, castor oil, almond oil, canola oil, hazelnut oil, pistachio oil, linseed oil, borage oil, hemp oil, jojoba oil, sunflower oil, wheat germ oil, corn and / or corn germ oil, peanut oil, avocado oil, safflower oil, rapeseed oil, olive oil, argan oil, sunflower oil, grapeseed oil, soybean oil, walnut oil, pumpkin seed oil, palm oil, coconut oil, and mixtures thereof. The oil can also be a derivative of one of the vegetable oils mentioned previously. It may be hydrogenated or non-hydrogenated, peroxidized or non-peroxidized; and their mixtures.

[0045] For example, the content of film-forming auxiliary agent can range from 0.05 to 5% and in particular from 0.1 to 3% by weight relative to the total weight of the composition. Additives

[0046] The composition according to the invention may include one or more pharmaceutically acceptable additives, such as perfumes, aromas, colorants, pigments, mattifying agents, rheological agents, preservatives, vitamins, essential oils and active agents, in particular selected from antibacterial agents, antiseptics, antivirals, antifungal agents, pain relievers, anti-inflammatories, healing agents, moisturizing agents, depigmenting agents, keratolytic agents, restructuring agents, anesthetics, sunscreens, and mixtures thereof.

[0047] In particular, the active ingredients that can be introduced into the composition according to the invention can be chosen from: antibacterials such as Polymyxin B, penicillins (Amoxicillin), clavulanic acid, tetracyclines, Minocycline, chlorotetracycline, aminoglycosides, Amikacin, Gentamicin, Neomycin, silver and its salts (silver sulfadiazine), probiotics; antiseptics such as sodium mercurothiolate, eosin, chlorhexidine, phenylmercury borate, hydrogen peroxide, Dakin's solution, triclosan, biguanide, hexamidine, thymol, Lugol's solution, povidone-iodine, merbromine, benzalkonium and benzethonium chloride, ethanol, isopropanol; antivirals such as aciclovir, famciclovir, ritonavir; antifungals such as polyenes, nystatin, amphotericin B, natamycin, imidazoles (miconazole, ketoconazole, clotrimazole, econazole, bifonazole, butoconazole, fenticonazole, isoconazole, oxiconazole, sertaconazole, sulconazole, thiabendazole, tioconazole), triazoles (fluconazole,Itraconazole, Ravuconazole, Posaconazole, Voriconazole), allylamines, Terbinafine, Amorolfine, Naftifine, Butenafine; Flucytosine (antimabolite), Griseofulvin, Caspofungin, Micafungin; painkillers such as Paracetamol, Codeine, Dextropropoxyphene, Tramadol, Morphine and its derivatives, Corticosteroids and derivatives; Anti-inflammatory drugs such as glucocorticoids, non-steroidal anti-inflammatory drugs (NSAIDs), aspirin, ibuprofen, ketoprofen, flurbiprofen, diclofenac, aceclofenac, ketorolac, meloxicam, piroxicam, tenoxicam, naproxen, indomethacin, naproxcinod, nimesulide, celecoxib, etoricoxib, parecoxib, rofecoxib, valdecoxib, phenylbutazone, niflumic acid, and mefenamic acid; active ingredients that promote healing such as retinol, vitamin A, vitamin E, N-acetylhydroxyproline, metformin, Centella asiatica extracts, papain, and silicones;essential oils of thyme, niaouli, rosemary and sage, hyaluronic acid, synthetic polysulfated oligosaccharides having 1 to 4 sugar units such as potassium salt of sucrose octasulfate, silver salt of sucrose octasulfate or sucralfate, allantoin; moisturizing agents such as hyaluronic acid, urea, glycerol, fatty acids, aquaporin modulators, vegetable oils, chitosan, certain sugars including sorbitol, butters and waxes; depigmenting agents such as kojic acid (Kojic Acid SL ®< - Quimasso (Sino Lion)), arbutin (Olevatin ®< - Quimasso (Sino Lion)), a mixture of sodium palmitoylpropyl and white water lily extract (Sepicalm ®< - Seppic), undecylenoyl phenylalanine (Sepiwhite ®< - Seppic), licorice extract obtained by fermentation of Aspergillus and ethoxydiglycol (Gatuline Whitening ®< - Gattefossé), octadecenedioic acid (ODA White ®< - Sederma), alpha-arbutin (Alpha-arbutin ®< ,SACI-CFPA (Pentapharm)), Arctophylos Uva Ursi aqueous leaf extract (Melfade-J ®< - SACI-CFPA (Pentapharm)), Gigawhite ®< complex plant blend (SACI-CFPA (Alpaflor)), diacetyl boldine (Lumiskin ®< - Sederma), Japanese mandarin extract (Melaslow ®< - Sederma), lemon extract blend enriched with citric acid and cucumber extract (Uninontan ®< U-34 - Unipex), Rumex occidentalis extract blend and vitamin C (Tyrostat ®< 11 - Unipex), oligopeptides (Melanostatin 5 ®< - Unipex), kojic dipalmitate (KAD-15 ®< - Quimasso (Sino Lion)), LCW's Vegewhite ®< natural origin complex, germ extracts wheat (Clariskin ®< II - Silab), ethyldiamine triacetate (EDTA); keratolytic agents such as salicylic acid, zinc salicylate, ascorbic acid, alpha hydroxy acids (glycolic, lactic, malic, citric, tartaric acid), extracts of silver maple, sour cherry, tamarind, urea,topical retinoid Keratoline ®< (Sederma), proteases obtained by fermentation of Bacillus Subtilis, the product Linked-Papain ®< (SACI-CFPA), papain (proteolytic enzyme from papaya fruit); restructuring actives (e.g., hair and nail restructuring agents) such as silica derivatives, vitamin E, chamomile, calcium, horsetail extract, silk lipester; anesthetics such as benzocaine, lidocaine, dibucaine, pramoxine hydrochloride, bupivacaine, mepivacaine, prilocaine, etidocaine; sunscreens, such as chemical filters (Oxybenzone, Sulisobenzone, Dioxybenzone, Tinosorb S ®< , Avobenzone, 2-ethoxyethyl p-methoxycinnamate, Uvinul ®< A+, Mexoryl ®< XL, Octyl methoxycinnamate or octinoxate, Octyl salicylate or octisalate, Octyl triazone or Uvinul ®< T 150, Methyl salicylate, Meradimate, Enzacamene, MBBT or Tinosorb ®< M, Octyl cyanophenylcinnamate or Parsol ®< 340, Para-aminobenzoic acid,Ensulizole, Parsol®< SLX or Polysiloxane-15 or Benzylidene malonate polysiloxane, triethanolamine salicylate or trolamine salicylate, Mexoryl®< SX or dicamphosulfonic acid terephthalylidene) and mineral filters (zinc oxides, titanium dioxide, kaolin, ichthyol). Film preparation

[0048] According to a particular embodiment, the invention relates to a method for obtaining a film from a film-forming composition as described above, comprising the following steps: i. Apply a composition as described above to the weakened nails so as to form a uniform liquid film, ii. Let it dry for 1 to 5 minutes.

[0049] The thickness of the uniform liquid film is for example greater than 500 nm, preferably between 1 and 300 µm, more preferably between 2 and 200 µm.

[0050] The invention also relates to a film that can be obtained from the process described above. Therapeutic use for the protection of the skin, mucous membranes or hair / nails

[0051] According to a particular embodiment, the invention relates to the film-forming composition or film as described above, for use in protecting skin, mucous membranes or hair.

[0052] Thus, the composition or film according to the invention can in particular be used as a liquid dressing, preferably for the protection of wounds, lesions, scars, burned tissues and / or skin conditions. Cosmetic nail treatment method

[0053] The invention also relates to a cosmetic treatment method for brittle nails comprising applying the previously described composition to the nails, preferably at least once a day, more preferably twice a day. Preferably, the application to the nails is carried out over a period of at least seven days, preferably at least fourteen days.

[0054] The cosmetic method of the invention makes it possible in particular to improve the appearance and / or strengthen weakened nails. Thus, the invention also relates to the use of the film-forming composition or the film as described above to improve the appearance and / or strengthen weakened nails.

[0055] The invention will be described in more detail with the help of the following examples, which are given purely for illustrative purposes and are not intended to be limiting. Example 1

[0056] The following composition has been prepared: Example 1 Trade name INCI Name % mass water 33.71 denatured alcohol 54.72 Sepinov EMT 10 is marketed by the company SEPPIC. copolymer of a sodium salt of 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid and the 2-hydroxyethyl ester of propenoic acid 3.75 glycerin 3 squalane 2.55 Polysorbate 60 0.55 Hydrolyzed keratin 0.525 phenoxyethanol 0.09 potassium sorbate 0.09 sodium benzoate 0.015 scent 1

[0057] The composition according to example 1 was prepared by mixing water and alcohol, then hydrolyzed keratin, glycerin, squalane, polysorbate 60, phenoxyethanol, potassium sorbate, sodium benzoate and perfume were added until a homogeneous mixture was obtained. Example 2: Evaluation of the effectiveness of the composition according to example 1 for treating brittle nails

[0058] 22 female volunteers aged between 22 and 68 years with brittle nails (i.e. brittle, split, thin or soft without any link to a pathology) tested the product according to example 1.

[0059] This product was applied to the nails twice a day for 28 days.

[0060] The objective of the evaluation is: to evaluate the effectiveness of the product studied on the appearance of weakened nails; to evaluate its repairing and strengthening / hardening effect; to subjectively evaluate its organoleptic characteristics and its effectiveness; to evaluate the persistence of the product, by the volunteers, 14 days after stopping treatment.

[0061] The evaluation criteria are: clinical scoring by the dermatologist (using structured scales); measurement of changes in Transepidermal Water Loss (Aquaflux ®); collection of adverse effects.

[0062] These criteria are assessed before treatment (Day 0), 14 days after the start of treatment (Day 14) and 28 days after the start of treatment (Day 28).

[0063] The following evaluation criteria are also determined: Subjective evaluation (questionnaire) at 72 h after the 1st application (t72h), 7 days after the start of treatment (J7), 14 days after the start of treatment (J14), 28 days after the start of treatment (J28) and 42 days after the start of treatment (J42); measurement of nail thickness (DermaScan C ®< ) at J0 and J28. 1. Visual Scoring

[0064] The dermatologist responsible for the evaluation performed a visual scoring of the nail condition (scoring the most affected nail on the treated hand) at the beginning of the study before product application, then after 14 days of treatment, and at the end of the study after 28 days of treatment. He assessed nail splitting, nail thinness, nail fragility, nail softness, nail color, and nail ridges. 2. Measurement of the restorative effect

[0065] The dermatologist also assessed the restorative effect of the composition in Example 1 by measuring changes in Transepidermal Water Loss (TEWL). When the skin barrier and nail plate are damaged, disruptions occur in the regulation of water exchange. Water then migrates more easily to the external environment, increasing TEWL. Conversely, if the condition of the skin barrier and nail plate improves, water loss values ​​decrease because the regulation of water exchange is properly maintained.

[0066] The PIE (Potential Insulation Effect) is calculated by evaporation, determining the pressure gradient of the water vapor layer. This technique is particularly useful for evaluating the restorative effects of a product.

[0067] PIE measurements are performed using an Aquaflux ®< AF100 condenser chamber (Biox Systems Ltd.).

[0068] The Aquaflux® measuring chamber is a hollow cylinder. Its lower end acts as a measuring orifice, which is placed in contact with the test surface (2.6 mm orifice). A specific adapter is used for applying the device to fingernails. Its upper end is sealed with an aluminum condenser, which is maintained at a temperature of -7.6°C. When a measurement is taken, the chamber is sealed, protecting the air inside from ambient airflow. The Aquaflux® measures the evaporation rate of a volatile substance (in this case, water). This value is expressed in g / m² / h.

[0069] The measurements are duplicated (one measurement on two different nails) on the treated hand. The nails measured are chosen according to the nail morphology of each volunteer, in order to take measurements on the largest and flattest nails possible.

[0070] This measurement is taken before the first application of the product and then after 14 and 28 days of treatment. 3. Nail thickness

[0071] The measurements are performed directly in vivo, using a high-frequency ultrasound scanner: the DermaScan C ®< 2D.

[0072] The measurement principle is that of ultrasound: an ultrasound beam is emitted by a piezoelectric ceramic. This beam is partially reflected by the interfaces separating two media with different ultrasound impedances.

[0073] The ultrasound scanner used is equipped with a 20 MHz probe. The probe is applied directly to the skin. A contact gel ensures homogeneous signal diffusion.

[0074] This method allows a two-dimensional visualization of the nail plate and the measurement of its thickness (in mm).

[0075] This measurement is taken before the first application of the product and then after 28 days of treatment. 4. Subjective evaluation questionnaire

[0076] A questionnaire is completed by the volunteers at t72h, J7, J14, J28 and J42 in order to subjectively evaluate the characteristics of the product studied, its overall effectiveness as well as its subsequent use. 5. Results

[0077] The product according to example 1 presents the following on dermatological clinical examination: a significant beneficial effect on nail splitting after 14 and 28 days of use; a significant beneficial effect on nail thinning after 14 and 28 days of use; a significant beneficial effect on nail brittleness after 14 and 28 days of use; a significant beneficial hardening effect after 14 and 28 days of use; a beneficial effect on nail color after 14 and 28 days of use; a beneficial smoothing effect after 14 and 28 days of use.

[0078] The objective measurements highlight the following for the product according to example 1: an objective repair effect by a significant reduction in PIE after 4 weeks of care; a significant increase in nail thickness measured by DermaScan ®< after 4 weeks of care, resulting in stronger, more solid nails.

[0079] The product shown in example 1 is appreciated by the majority of volunteers: After just three days of application, 59% of volunteers reported an improvement in the appearance of their nails treated with the product being tested. More than half of the volunteers (55%) found their nails better nourished and protected, 46% found their nails stronger, 45% found them better hydrated and less brittle, 32% found them harder, and 27% found them less prone to splitting and repair. The product is therefore effective quickly. By the seventh day of application, 77% of volunteers noted an improvement in the appearance of their nails, with the effect of the tested product being optimal across the majority of parameters studied. 73% of volunteers found their nails better nourished and strengthened, 68% better hydrated and protected, and 64% less brittle. After one week of treatment, the appearance of nails is improved in more than 3 out of 4 volunteers. After 7 days of application, nails are better nourished, strengthened, hydrated, protected and less brittle in more than 60% of volunteers.After two weeks of application, 82% of volunteers noted an improvement in the appearance of their nails. The product's effect was optimal on nail hardness, with 69% of volunteers finding their nails harder. After two weeks of treatment, the appearance of nails was improved in more than 8 out of 10 volunteers. Nails were harder in 7 out of 10 volunteers. After 28 days of treatment, nails treated with the product were better nourished (69% of subjects), more hydrated (68% of subjects), repaired (69% of subjects), strengthened (72% of subjects), harder (69% of subjects), less brittle (60% of subjects), and less prone to splitting (59% of subjects). According to 87% of subjects, the appearance of their nails improved on day 28 compared to day 0, in comparison to the untreated area.The product's effectiveness in improving nail condition is still visible 14 days after stopping treatment; indeed, 73% of volunteers still notice an improvement in the appearance of their nails compared to their appearance on the last day of treatment, attesting to a persistence of the beneficial effect, and 82% of subjects find that the appearance of their nails is still improved compared to their untreated nails on day 42.

Claims

1. Film-forming liquid composition, characterized in that it comprises, in a pharmaceutically acceptable medium, - at least one keratin-derived film-forming polymer present in the composition in a solids content ranging from 0.2% to 1% by weight, relative to the total weight of the composition; - at least one moisturizing agent chosen from the group consisting of glycerol in combination with squalane, present in the composition in a solids content ranging from 1% to 10% by weight; and - at least one surfactant chosen from plant gums, polyacrylic acids, polyethylene glycol, polysorbates, and mixtures thereof, present in the composition in a solids content ranging from 1% to 10%; and the composition being characterized in that it comprises neither formaldehyde nor paraben.

2. Composition according to Claim 1, characterized in that the keratin-derived film-forming polymer is hydrolyzed keratin.

3. Composition according to Claim 1 or 2, characterized in that the moisturizing agent is present in a solids content ranging from 2% to 7% by weight, relative to the total weight of the composition.

4. Composition according to any one of Claims 1 to 3, characterized in that the surfactant is present in a solids content ranging from 2% to 6% by weight, relative to the total weight of the composition.

5. Composition according to any one of Claims 1 to 4, characterized in that the surfactant is a copolymer of a 2-methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid salt and of the 2-hydroxyethyl ester of propenoic acid used alone or in combination with a polysorbate, preferably polysorbate 60.

6. Process for obtaining a film, characterized in that: i. a composition according to any one of Claims 1 to 5 is applied to embrittled nails in such a way as to form a uniform liquid film, ii. it is left to dry for 1 to 5 minutes.

7. Film obtainable from the process according to Claim 6.

8. Film according to Claim 7, for use thereof in protecting the skin, the skin appendages and the mucous membranes.

9. Method for the cosmetic treatment of embrittled nails, comprising the application of the composition according to any one of Claims 1 to 5 to the nails, preferably at least once a day, more preferentially twice a day.

10. Cosmetic treatment method according to Claim 9, in which the composition is applied to the nails for a period of at least seven days, preferably at least fourteen days.

11. Use of the composition according to any one of Claims 1 to 5 or of the film according to Claim 7, for improving the appearance of and / or reinforcing embrittled nails.